104 related articles for article (PubMed ID: 7946257)
1. Opioid antagonist effects on self-injury in adults with mental retardation: response form and location as determinants of medication effects.
Thompson T; Hackenberg T; Cerutti D; Baker D; Axtell S
Am J Ment Retard; 1994 Jul; 99(1):85-102. PubMed ID: 7946257
[TBL] [Abstract][Full Text] [Related]
2. Case study: paradoxical response to naltrexone treatment of self-injurious behavior.
Benjamin S; Seek A; Tresise L; Price E; Gagnon M
J Am Acad Child Adolesc Psychiatry; 1995 Feb; 34(2):238-42. PubMed ID: 7896657
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine treatment of severe self-injury in young adults with mental retardation.
Ricketts RW; Goza AB; Ellis CR; Singh YN; Singh NN; Cooke JC
J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):865-9. PubMed ID: 8340311
[TBL] [Abstract][Full Text] [Related]
4. An orally administered opiate blocker, naltrexone, attenuates self-injurious behavior.
Sandman CA; Barron JL; Colman H
Am J Ment Retard; 1990 Jul; 95(1):93-102. PubMed ID: 2167107
[TBL] [Abstract][Full Text] [Related]
5. Preliminary study of altered skin temperature at body sites associated with self-injurious behavior in adults who have developmental disabilities.
Symons FJ; Sutton KA; Bodfish JW
Am J Ment Retard; 2001 Jul; 106(4):336-43. PubMed ID: 11414874
[TBL] [Abstract][Full Text] [Related]
6. Clinical effects of naltrexone on autistic behavior.
Zingarelli G; Ellman G; Hom A; Wymore M; Heidorn S; Chicz-DeMet A
Am J Ment Retard; 1992 Jul; 97(1):57-63. PubMed ID: 1497864
[TBL] [Abstract][Full Text] [Related]
7. Self-injurious behavior and the efficacy of naltrexone treatment: a quantitative synthesis.
Symons FJ; Thompson A; Rodriguez MC
Ment Retard Dev Disabil Res Rev; 2004; 10(3):193-200. PubMed ID: 15611982
[TBL] [Abstract][Full Text] [Related]
8. Adult head-banging and stereotypic movement disorders.
Mendez MF; Mirea A
Mov Disord; 1998 Sep; 13(5):825-8. PubMed ID: 9756153
[TBL] [Abstract][Full Text] [Related]
9. Naltrexone and fluoxetine in Prader-Willi syndrome.
Benjamin E; Buot-Smith T
J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):870-3. PubMed ID: 8340312
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of naltrexone on self-injurious behavior.
Sandman CA; Hetrick W; Taylor DV; Marion SD; Touchette P; Barron JL; Martinezzi V; Steinberg RM; Crinella FM
Am J Ment Retard; 2000 Mar; 105(2):103-17. PubMed ID: 10755174
[TBL] [Abstract][Full Text] [Related]
11. Effects of risperidone on aberrant behavior of persons with developmental disabilities: I. A double-blind crossover study using multiple measures.
Zarcone JR; Hellings JA; Crandall K; Reese RM; Marquis J; Fleming K; Shores R; Williams D; Schroeder SR
Am J Ment Retard; 2001 Nov; 106(6):525-38. PubMed ID: 11708938
[TBL] [Abstract][Full Text] [Related]
12. Clomipramine treatment of stereotypic behaviors and self-injury in patients with developmental disabilities.
Garber HJ; McGonigle JJ; Slomka GT; Monteverde E
J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1157-60. PubMed ID: 1429420
[TBL] [Abstract][Full Text] [Related]
13. Effects of Snoezelen room, Activities of Daily Living skills training, and Vocational skills training on aggression and self-injury by adults with mental retardation and mental illness.
Singh NN; Lancioni GE; Winton AS; Molina EJ; Sage M; Brown S; Groeneweg J
Res Dev Disabil; 2004; 25(3):285-93. PubMed ID: 15134793
[TBL] [Abstract][Full Text] [Related]
14. Self-injurious behavior in the developmentally disabled: pharmacologic treatment.
Osman OT; Loschen EL
Psychopharmacol Bull; 1992; 28(4):439-49. PubMed ID: 1296222
[TBL] [Abstract][Full Text] [Related]
15. [Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone].
Leboyer M; Bouvard MP; Launay JM; Recasens C; Plumet MH; Waller-Perotte D; Tabuteau F; Bondoux D; Dugas M
Encephale; 1993; 19(2):95-102. PubMed ID: 8275903
[TBL] [Abstract][Full Text] [Related]
16. Naltrexone in autistic children: behavioral symptoms and attentional learning.
Campbell M; Anderson LT; Small AM; Adams P; Gonzalez NM; Ernst M
J Am Acad Child Adolesc Psychiatry; 1993 Nov; 32(6):1283-91. PubMed ID: 8282676
[TBL] [Abstract][Full Text] [Related]
17. Clinical effects of buspirone on intractable self-injury in adults with mental retardation.
Ricketts RW; Goza AB; Ellis CR; Singh YN; Chambers S; Singh NN; Cooke JC
J Am Acad Child Adolesc Psychiatry; 1994 Feb; 33(2):270-6. PubMed ID: 8150800
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and fluoxetine treatment of compulsive behavior disorder of adults with mental retardation.
Bodfish JW; Madison JT
Am J Ment Retard; 1993 Nov; 98(3):360-7. PubMed ID: 8292312
[TBL] [Abstract][Full Text] [Related]
19. Opiate antagonists for recurrent self-injurious behavior in three mentally retarded adults.
Buzan RD; Dubovsky SL; Treadway JT; Thomas M
Psychiatr Serv; 1995 May; 46(5):511-2. PubMed ID: 7627682
[TBL] [Abstract][Full Text] [Related]
20. Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial.
Roth AS; Ostroff RB; Hoffman RE
J Clin Psychiatry; 1996 Jun; 57(6):233-7. PubMed ID: 8666558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
